The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of iparomlimab and tuvonralimab in combination with gemcitabine and cisplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase 2 trial (DUBHE-N-302).
 
Yan Huang
No Relationships to Disclose
 
Shen Zhao
No Relationships to Disclose
 
Song Qu
No Relationships to Disclose
 
Ying Guan
No Relationships to Disclose
 
Yuanyuan Zhao
No Relationships to Disclose
 
Jie Wang
Employment - QiLu Pharmaceutical
 
Ting Wu
Employment - QiLu Pharmaceutical
 
Xiaokui Yu
Employment - QiLu Pharmaceutical
 
Shilin Xue
Employment - QiLu Pharmaceutical
 
Xiaoyan Kang
Employment - QiLu Pharmaceutical
 
Li Zhang
No Relationships to Disclose